| Ronald G Navone, M.d., A Professional Corporation | |
|
845 S Fairmont Ave Ste 5 Lodi CA 95240-5113 | |
| (209) 366-2360 | |
| (209) 366-2352 |
| Full Name | Ronald G Navone, M.d., A Professional Corporation |
|---|---|
| Speciality | Internal Medicine |
| Location | 845 S Fairmont Ave Ste 5, Lodi, California |
| Authorized Official Name and Position | Ronald G Navone (PRESIDENT) |
| Authorized Official Contact | 2093662360 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ronald G Navone, M.d., A Professional Corporation 845 S Fairmont Ave Ste 5 Lodi CA 95240-5113 Ph: (209) 366-2360 | Ronald G Navone, M.d., A Professional Corporation 845 S Fairmont Ave Ste 5 Lodi CA 95240-5113 Ph: (209) 366-2360 |
| NPI Number | 1316137854 |
|---|---|
| Provider Enumeration Date | 07/31/2007 |
| Last Update Date | 05/21/2015 |
| Medicare PECOS PAC ID | 5890724769 |
|---|---|
| Medicare Enrollment ID | O20050810001155 |
News Archive
A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine developers.
Thoratec Corporation, a manufacturer of products to treat cardiovascular disease, has announced the expansion of its Phase I feasibility trial for the HeartMate(R) II left ventricular assist system (LVAS).
Laboratory testing by Charité - Universitätsmedizin Berlin, the Bundeswehr Institute of Microbiology and Munich Clinic Schwabing has revealed that infectious virus can be isolated from nose and throat swabs even where these have been obtained from patients with mild symptoms.
Teva Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited (Takeda) today announced the signing earlier this year of an agreement in which Teva licensed to Takeda the right to commercialize Teva's innovative glatiramer acetate ( active ingredient) formulation for the treatment of multiple sclerosis, in Japan.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316137854 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Ronald G Navone |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1225144934 PECOS PAC ID: 0345285003 Enrollment ID: I20050622001385 |
News Archive
A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine developers.
Thoratec Corporation, a manufacturer of products to treat cardiovascular disease, has announced the expansion of its Phase I feasibility trial for the HeartMate(R) II left ventricular assist system (LVAS).
Laboratory testing by Charité - Universitätsmedizin Berlin, the Bundeswehr Institute of Microbiology and Munich Clinic Schwabing has revealed that infectious virus can be isolated from nose and throat swabs even where these have been obtained from patients with mild symptoms.
Teva Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited (Takeda) today announced the signing earlier this year of an agreement in which Teva licensed to Takeda the right to commercialize Teva's innovative glatiramer acetate ( active ingredient) formulation for the treatment of multiple sclerosis, in Japan.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
› Verified 2 days ago
News Archive
A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine developers.
Thoratec Corporation, a manufacturer of products to treat cardiovascular disease, has announced the expansion of its Phase I feasibility trial for the HeartMate(R) II left ventricular assist system (LVAS).
Laboratory testing by Charité - Universitätsmedizin Berlin, the Bundeswehr Institute of Microbiology and Munich Clinic Schwabing has revealed that infectious virus can be isolated from nose and throat swabs even where these have been obtained from patients with mild symptoms.
Teva Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited (Takeda) today announced the signing earlier this year of an agreement in which Teva licensed to Takeda the right to commercialize Teva's innovative glatiramer acetate ( active ingredient) formulation for the treatment of multiple sclerosis, in Japan.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
› Verified 2 days ago
Lodi Memorial Community Clinic-alder Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2407 W Vine St, Suite A, Lodi, CA 95242 Phone: 209-334-3411 Fax: 209-339-7659 | |
Lodi Ave Care Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1300 W Lodi Ave, Ste P, Lodi, CA 95242 Phone: 209-366-1990 | |
James S. Hoff, M.d., A Medical Corporation Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 999 S Fairmont Ave, Suite 135, Lodi, CA 95240 Phone: 209-224-5719 Fax: 209-691-9521 | |
Cmc, Lodi Vine Family Care, Suite 105 Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2415 W Vine St Ste 105, Lodi, CA 95242 Phone: 209-333-3121 | |
Fairmont Ave Care Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 999 S Fairmont Ave, #130/135, Lodi, CA 95240 Phone: 209-366-2001 | |
Lodi Memorial Urgent Care Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1235 W Vine St Ste 20, Lodi, CA 95240 Phone: 209-339-7625 Fax: 209-339-7659 | |
Inpatient Services Of California, Inc., A Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 975 S. Fairmont Ave, Lodi, CA 95240 Phone: 214-712-2400 |